Skip to main content

Table 1 Demographic and clinical characteristics of the study population

From: Association of the lymphocyte-to-monocyte ratio, mean diameter of coronary arteries, and uric acid level with coronary slow flow in isolated coronary artery ectasia

 

NCSF group (n = 55)

CSF group (n = 71)

p

Age

55.73 ± 11.93

55.85 ± 11.06

0.954

Male

34 (61.8%)

60 (84.5%)

0.004

BMI

26.29 ± 4.97

27.15 ± 3.41

0.251

Smoking history

24 (43.6%)

45 (63.4%)

0.021

Anti-platelet drugs

30 (54.5%)

36 (50.7%)

0.402

β-blockers

19 (34.5%)

23 (32.4%)

0.474

ACE inhibitors

6 (10.9%)

5 (7%)

0.326

ARBs

8 (14.5%)

10 (14.1%)

0.569

Statins

26 (47.3%)

31 (43.7%)

0.411

Hypertension

36 (65.5%)

42 (59.2%)

0.296

Diabetes

13 (23.6%)

10 (14.1%)

0.276

LVEF

64.11 ± 4.20

48.68 ± 4.16

0.264

LVEDd

48.44 ± 4.33

48.68 ± 4.16

0.753

CAE in LAD (%)

29 (52.7%)

52 (73.2%)

0.044

CAE in LCX (%)

14 (25.5%)

41 (57.7%)

0.001

CAE in RCA (%)

31 (56.4%)

52 (73.2%)

0.111

CAE in 1 vessel

33 (60%)

21 (29.6%)

0.001

CAE in 2 vessels

15 (27.3%)

26 (36.6%)

0.001

CAE in 3 vessels

7 (12.7%)

24 (33.8%)

0.001